Variant report

Variant	esv3468808
Chromosome Location	chr11:10291076-10295774
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:40)
CpG islands
(count:0)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:40 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr11:10293859-10294109	A549	lung:	n/a	n/a
2	CEBPB	chr11:10293851-10294053	IMR90	lung:	n/a	n/a
3	CEBPB	chr11:10293799-10294157	A549	lung:	n/a	n/a
4	CTCF	chr11:10294430-10294547	GM20000	blood:	n/a	n/a
5	CTCF	chr11:10293265-10293308	Kidney_OC	kidney:	n/a	n/a
6	CTCF	chr11:10294439-10294509	Kidney_OC	kidney:	n/a	n/a
7	FOS	chr11:10293895-10294012	MCF10A-Er-Src	breast:	n/a	n/a
8	FOS	chr11:10293822-10294052	MCF10A-Er-Src	breast:	n/a	n/a
9	HEY1	chr11:10293559-10293883	HepG2	liver:	n/a	n/a
10	HEY1	chr11:10293612-10293853	K562	blood:	n/a	n/a
11	POLR2A	chr11:10293703-10293824	A549	lung:	n/a	n/a
12	POLR2A	chr11:10293714-10293891	H1-hESC	embryonic stem cell:	n/a	n/a
13	POLR2A	chr11:10293474-10293821	Gliobla	brain:	n/a	n/a
14	POLR2A	chr11:10293713-10293809	GM12878	blood:	n/a	n/a
15	POLR2A	chr11:10293541-10293834	HUVEC	blood vessel:	n/a	n/a
16	POLR2A	chr11:10293559-10293825	Hela-S3	cervix:	n/a	n/a
17	POLR2A	chr11:10293667-10293861	A549	lung:	n/a	n/a
18	POLR2A	chr11:10293508-10293828	K562	blood:	n/a	n/a
19	POLR2A	chr11:10293695-10293833	HepG2	liver:	n/a	n/a
20	POLR2A	chr11:10295428-10295539	H1-hESC	embryonic stem cell:	n/a	n/a
21	POLR2A	chr11:10293530-10294025	ProgFib	skin:	n/a	n/a
22	POLR2A	chr11:10293677-10293853	Hela-S3	cervix:	n/a	n/a
23	POLR2A	chr11:10293553-10293818	H1-hESC	embryonic stem cell:	n/a	n/a
24	POLR2A	chr11:10293610-10293904	Hela-S3	cervix:	n/a	n/a
25	POLR2A	chr11:10293694-10293840	GM12878	blood:	n/a	n/a
26	POLR2A	chr11:10293654-10293827	A549	lung:	n/a	n/a
27	POLR2A	chr11:10293540-10293822	A549	lung:	n/a	n/a
28	POLR2A	chr11:10293687-10293837	GM12878	blood:	n/a	n/a
29	POLR2A	chr11:10295416-10295425	Gliobla	brain:	n/a	n/a
30	POLR2A	chr11:10293690-10293826	A549	lung:	n/a	n/a
31	POLR2A	chr11:10293528-10293830	MCF-7	breast:	n/a	n/a
32	POLR2A	chr11:10293476-10293888	GM12892	blood:	n/a	n/a
33	POLR2A	chr11:10293500-10293830	MCF-7	breast:	n/a	n/a
34	POLR2A	chr11:10293559-10293821	MCF-7	breast:	n/a	n/a
35	POLR2A	chr11:10293677-10293845	HepG2	liver:	n/a	n/a
36	STAT3	chr11:10293874-10294074	MCF10A-Er-Src	breast:	n/a	n/a
37	STAT3	chr11:10293837-10294090	MCF10A-Er-Src	breast:	n/a	n/a
38	STAT3	chr11:10290835-10291160	MCF10A-Er-Src	breast:	n/a	n/a
39	STAT3	chr11:10293763-10294039	MCF10A-Er-Src	breast:	n/a	n/a
40	USF2	chr11:10295435-10295438	H1-hESC	embryonic stem cell:	n/a	n/a

No data

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:10284644..10286841-chr11:10289235..10291262,2	MCF-7	breast:
2	chr11:10293712..10297432-chr11:10324720..10326890,3	MCF-7	breast:
3	chr11:10260654..10262324-chr11:10295566..10297220,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000254719	TF binding region
ENSG00000148926	chromatin interactions
ENSG00000254554	chromatin interactions

Extended variants
information (count: 161 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:161 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs569524671	chr11:10291313-10291314	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs370912040	chr11:10291316-10291317	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs538437248	chr11:10291351-10291352	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs558470883	chr11:10291382-10291383	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs572283768	chr11:10291393-10291394	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs374868576	chr11:10291431-10291432	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs540304710	chr11:10291543-10291544	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs186767637	chr11:10291688-10291689	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs573926473	chr11:10291702-10291703	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs199864388	chr11:10291712-10291713	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs138414144	chr11:10291755-10291756	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs543149637	chr11:10291765-10291766	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs562926802	chr11:10291856-10291857	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs191582945	chr11:10291860-10291861	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs112977775	chr11:10291932-10291933	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs151038454	chr11:10291968-10291969	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs367905694	chr11:10291971-10291972	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs2957671	chr11:10292003-10292004	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs116591914	chr11:10292005-10292006	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs547739157	chr11:10292028-10292029	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs187053307	chr11:10292107-10292108	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs193023325	chr11:10292117-10292118	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs75372515	chr11:10292120-10292121	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs58354844	chr11:10292146-10292147	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs185256541	chr11:10292225-10292226	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs374264755	chr11:10292229-10292230	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs190499085	chr11:10292232-10292233	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs552334392	chr11:10292262-10292263	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs182257788	chr11:10292266-10292267	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs565704659	chr11:10292268-10292269	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs534941444	chr11:10292271-10292272	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs554523062	chr11:10292307-10292308	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs573984409	chr11:10292365-10292366	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs112363006	chr11:10292426-10292427	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs369544329	chr11:10292440-10292441	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs183709117	chr11:10292473-10292474	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs11042712	chr11:10292477-10292478	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs111329037	chr11:10292518-10292519	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs545650358	chr11:10292596-10292597	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs188461485	chr11:10292633-10292634	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs572519539	chr11:10292653-10292654	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs541714447	chr11:10292684-10292685	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs142398473	chr11:10292731-10292732	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs35931698	chr11:10292761-10292762	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs375984166	chr11:10292795-10292796	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs529687964	chr11:10292940-10292941	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs1802835	chr11:10293125-10293126	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs549344971	chr11:10293141-10293142	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs374709754	chr11:10293221-10293222	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs563079409	chr11:10293229-10293230	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Neuroblastoma	18923191	CNVD
Breast cancer	19432969	CNVD
Alzheimer''s disease	17576883	CNVD
Long-qt syndrome	17576883	CNVD
Emphysema	19352772	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Chordoma	18071362	CNVD
Breast cancer	16608533	CNVD
Cancer	21183584	CNVD
Gastric adenocarcinoma	19115996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Myelofibrosis	22110671	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Neuroblastoma	21124317	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Schizophrenia	21399695	CNVD
Gastric cancer	16891809	CNVD
Cancer	17160897	CNVD
Multiple myeloma	16616336	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD

Chromatin state (count:107 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:10268600-10300000	Weak transcription	Fetal Intestine Small	intestine
2	chr11:10277600-10292000	Weak transcription	Aorta	Aorta
3	chr11:10278200-10295200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
4	chr11:10278200-10309200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
5	chr11:10279000-10311400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
6	chr11:10279400-10296600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
7	chr11:10281200-10295000	Weak transcription	Cortex derived primary cultured neurospheres	brain
8	chr11:10285400-10303400	Weak transcription	Fetal Intestine Large	intestine
9	chr11:10287600-10306200	Weak transcription	Psoas Muscle	Psoas
10	chr11:10287800-10295400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
11	chr11:10288000-10295000	Weak transcription	Ovary	ovary
12	chr11:10288600-10294400	Weak transcription	Placenta	Placenta
13	chr11:10288800-10291200	Enhancers	HSMM	muscle
14	chr11:10289000-10291200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
15	chr11:10289000-10291200	Enhancers	A549	lung
16	chr11:10289000-10291400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr11:10289200-10299200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr11:10289400-10299200	Weak transcription	Small Intestine	intestine
19	chr11:10289600-10291400	Enhancers	Osteobl	bone
20	chr11:10289800-10291200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
21	chr11:10290000-10291200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr11:10290000-10291200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr11:10290000-10313400	Weak transcription	Fetal Brain Male	brain
24	chr11:10290200-10291400	Enhancers	NHLF	lung
25	chr11:10290400-10291200	Enhancers	Muscle Satellite Cultured Cells	--
26	chr11:10290400-10291200	Enhancers	Placenta Amnion	Placenta Amnion
27	chr11:10290400-10291200	Enhancers	Hela-S3	cervix
28	chr11:10290400-10291400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
29	chr11:10290600-10291200	Enhancers	Stomach Mucosa	stomach
30	chr11:10290600-10291200	Enhancers	NHEK	skin
31	chr11:10290600-10291400	Enhancers	HMEC	breast
32	chr11:10290800-10291400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr11:10290800-10291400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr11:10290800-10309000	Weak transcription	HSMMtube	muscle
35	chr11:10291000-10291400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
36	chr11:10291000-10293800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
37	chr11:10291000-10295000	Weak transcription	NHDF-Ad	bronchial
38	chr11:10291200-10292200	Weak transcription	Stomach Mucosa	stomach
39	chr11:10291200-10293600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
40	chr11:10291200-10293600	Weak transcription	A549	lung
41	chr11:10291200-10293800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
42	chr11:10291200-10293800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr11:10291200-10295000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
44	chr11:10291200-10295000	Weak transcription	Muscle Satellite Cultured Cells	--
45	chr11:10291200-10313600	Weak transcription	NHEK	skin
46	chr11:10291200-10314400	Weak transcription	HSMM	muscle
47	chr11:10291400-10293600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr11:10291400-10295200	Weak transcription	NHLF	lung
49	chr11:10291400-10295200	Weak transcription	Osteobl	bone
50	chr11:10291400-10296000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links